Page last updated: 2024-10-21

4-diphenylacetoxy-1,1-dimethylpiperidinium and Carcinoma, Small Cell

4-diphenylacetoxy-1,1-dimethylpiperidinium has been researched along with Carcinoma, Small Cell in 1 studies

4-diphenylacetoxy-1,1-dimethylpiperidinium: muscarinic receptor antagonist; RN given refers to parent cpd; do not confuse abbreviation 4-DAMP with a similar cpd which does not contain dimethyl groups
4-DAMP(1+) : A quaternary ammonium salt obtained by formal methylation of the tertiary amino function of 4-diphenylacetoxy-N-methylpiperidine.

Carcinoma, Small Cell: An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterized by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1286-7)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, S1
Togo, S1
Minakata, K1
Gu, T1
Ohashi, R1
Tajima, K1
Murakami, A1
Iwakami, S1
Zhang, J1
Xie, C1
Takahashi, K1

Other Studies

1 other study available for 4-diphenylacetoxy-1,1-dimethylpiperidinium and Carcinoma, Small Cell

ArticleYear
Distinct roles of cholinergic receptors in small cell lung cancer cells.
    Anticancer research, 2010, Volume: 30, Issue:1

    Topics: Blotting, Western; Carcinoma, Small Cell; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cholinergi

2010